No one liable for trial mishap

Bill shows the way

Stringent laws in India can control unethical practices

India’s mysterious diseases: The ailments that remain undiagnosed

There have been some diseases in India that have perplexed the government and medical fraternity for decades

New, affordable kits for diabetic patients to hit market soon

Kits developed by IIT-Bombay and BITS-Pilani will cost Rs 500 to Rs 800, and reduce cost of diabetes management

Experts contest new vaccine policy document

Say they were not consulted

Missing evidence

Questions are being raised about the authenticity of forensic samples of Bhopal gas victims, crucial for establishing the cause of deaths. Have …

Supreme Court issues notice to Centre on HPV vaccines for cervical cancer

Gardasil and Cervarix were approved by drugs controller even though they are unproven and hazardous, alleges petition

The new obesity

A growing number of people are unable to shed those extra pounds despite strict diet regimes and long hours of workout. Evidence shows that the …

Ranbaxy launches new anti-malarial drug

It has an efficacy rate of over 95 per cent, claims company

Supreme Court criticized for giving clearance to Bt Brinjal

Hidden hunger?

There is a rush to cash in on micronutrient deficiency in India through fortification of food

New victims

India is nowhere close to herd immunity, countrywide serosurvey shows

Upcoming winter season and festivals could heighten COVID-19 challenge, say officials

India’s COVID-19 vaccine: Study investigators say August 15 deadline unachievable

Indian Council of Medical research suggests a month’s time to complete three phases, global experiments taking months

ICMR launches three new diagnostic kits

They will help reduce costs of detecting pathogens in food, estimating iron levels in blood and determining vitamin A levels in blood under …

Can endosulfan be exported?

Supreme Court asks panel to explore possibilities of disposing of the pesticide  

Brief

Rules and renegades

Pesticide regulations in India are lax. The industry has exploited the loopholes to corrupt the system. And the government has turned a blind eye …

Industry's Nemesis

A report by the National Institute of Occupational Health nails endosulfan. Is that why the pesticide establishment wants to keep it under wraps?

ICMR D-G is wrong; Kawasaki disease in children post-COVID has been reported in India

Shut down schools if positivity rate goes up to more than 5 per cent: IAP chief

Deaths due to non-communicable diseases increased by 37 per cent since 1990

Kerala, Goa, and Tamil Nadu have the largest share of non-communicable diseases, according to the 2016 India State-level Disease Burden study

Supreme Court issues notices on unethical drug trials

1,727 persons have died during drug trials between 2007 and 2010, says public interest petition

Scientists get legal notice for highlighting health hazards of endosulfan

Excel Crop Care asks them to withdraw report, apologise publicly by July 28

Endosulfan: India in denial

Agriculture minister claims several states had asked him not to ban the pesticide

Convalescent plasma therapy may go off Indian protocol for COVID-19: ICMR

PM Modi urges citizens to follow precautions during upcoming festive season